VALIDATION OF A PANEL OF GENETIC MARKERS (CRS7) IN PREDICTING CIRRHOSIS, FIBROSIS PROGRESSION (FP) AND CLINICAL OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) IN THE HALT-C TRIAL

被引：0
|
作者：
Curto, Teresa M. [1 ]
Lok, Anna S. [2 ]
Lagier, Robert J. [4 ]
Rowland, Charles M. [4 ]
Sninsky, John [4 ]
Everhart, James E. [3 ]
机构：
[1] New England Res Inst, Watertown, MA 02172 USA
[2] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI USA
[3] NIDDK, Bethesda, MD USA
[4] Celera, Alameda, CA USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1620
引用
收藏
页码：1054A / 1054A
页数：1
相关论文
共 25 条
  • [1] Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7)
    Curto, Teresa M.
    Lagier, Robert J.
    Lok, Anna S.
    Everhart, James E.
    Rowland, Charles M.
    Sninsky, John J.
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (12): : 851 - 860
  • [2] Fibrosis Progression in Chronic Hepatitis C: Morphometric Image Analysis in the HALT-C Trial
    Goodman, Zachary D.
    Stoddard, Anne M.
    Bonkovsky, Herbert L.
    Fontana, Robert J.
    Ghany, Marc G.
    Morgan, Timothy R.
    Wright, Elizabeth C.
    Brunt, Elizabeth M.
    Kleiner, David E.
    Shiffmann, Mitchell L.
    Everson, Gregory T.
    Lindsay, Karen L.
    Dienstag, Jules L.
    Morishima, Chihiro
    HEPATOLOGY, 2009, 50 (06) : 1738 - 1749
  • [3] Rate of Progression of Hepatic Fibrosis in Patients With Chronic Hepatitis C: Results From the HALT-C Trial
    Hoefs, John C.
    Shiffman, Mitchell L.
    Goodman, Zachary D.
    Kleiner, David E.
    Dienstag, Jules L.
    Stoddard, Anne M.
    GASTROENTEROLOGY, 2011, 141 (03) : 900 - U629
  • [4] RATE OF PROGRESSION OF HEPATIC FIBROSIS IN PATIENT WITH CHRONIC HEPATITIS C (CHC) PREDICTS NON-HCC AND HCC OUTCOMES: RESULTS FROM THE HALT-C TRIAL
    Hoofs, John C.
    Shiffman, Mitchell L.
    Goodman, Zachary
    Kleiner, David E.
    Stoddard, Anne M.
    Dienstag, Jules L.
    HEPATOLOGY, 2010, 52 (04) : 412A - 412A
  • [5] RELATIONSHIP OF IRON [FE] AND HFE GENETIC VARIATIONS TO PROGRESSION AND OUTCOMES OF ADVANCED CHRONIC HEPATITIS C IN THE HALT-C TRIAL
    Lambrecht, Richard W.
    Naishadham, Deepa
    Sterling, Richard K.
    Rogers, Thomas E.
    Morishima, Chihiro
    Stoddard, Anne M.
    Bonkovsky, Herbert L.
    HEPATOLOGY, 2009, 50 (04) : 1050A - 1050A
  • [6] Progression of Advanced Chronic Hepatitis C (CHC): Further Follow-up Results From the Halt-C Trial
    Dienstag, Jules L.
    Bonkovsky, Herbert L.
    Kim, Hae-Young
    Seeff, Leonard B.
    Di Bisceglie, Adrian M.
    Szabo, Gyongyi
    Wright, Elizabeth C.
    GASTROENTEROLOGY, 2010, 138 (05) : S780 - S781
  • [7] Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: Results from the HALT-C trial
    Fontana, Robert J.
    Sanyal, Arun J.
    Mehta, Savant
    Doherty, Michael C.
    Neuschwander-Tetri, Brent A.
    Everson, Gregory T.
    Kahn, Jeffrey A.
    Malet, Peter F.
    Sheikh, Muhammad Y.
    Chung, Raymond T.
    Ghany, Marc G.
    Gretch, David R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (05): : 983 - 992
  • [8] SERUM FIBROSIS MARKERS ARE ASSOCIATED WITH CLINICAL OUTCOMES AND HISTOLOGICAL PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) AND ADVANCED FIBROSIS
    Fontana, Robert J.
    Lok, Anna S.
    Dienstag, Jules L.
    Naishadham, Deepa
    Bonkovsky, Herbert L.
    Wright, Elizabeth C.
    Goodman, Zachary D.
    Sterling, Richard K.
    HEPATOLOGY, 2009, 50 (04) : 1056A - 1057A
  • [9] COFFEE IS ASSOCIATED WITH VIROLOGIC RESPONSE IN CHRONIC HEPATITIS C (CHC): FINDINGS FROM THE HEPATITIS C LONG-TERM TREATMENT AGAINST CIRRHOSIS TRIAL (HALT-C)
    Freedman, Neal D.
    Curto, Teresa M.
    Lindsay, Karen
    Wright, Elizabeth C.
    Sinha, Rashmi
    Everhart, James E.
    HEPATOLOGY, 2010, 52 (04) : 434A - 435A
  • [10] Statin Use Reduces Risk of Progression of Liver Fibrosis, Among Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial
    Simon, Tracey G.
    King, Lindsay Y.
    Zheng, Hui
    Chung, Raymond T.
    GASTROENTEROLOGY, 2014, 146 (05) : S966 - S966
123